CPIX
Cumberland Pharmaceuticals Inc
$6.16
-0.21 (-3.30%)
At close · Jul 6
Market Cap
$92.30M
Shares
14,983,107
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$10,000,000
as of 2023-09-30
· not restated in filings since 2023-11-13
Remaining Authorization
$2,100,000
as of 2026-03-31
Program Utilization
79.0%
$7,900,000 used of $10,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $61,001 | 10-Q, filed 2026-05-08 |
| 2025-12-31 | $263,478 | 10-K, filed 2026-03-09 |
| 2024-12-31 | $579,049 | 10-K, filed 2026-03-09 |
| 2023-12-31 | $740,533 | 10-K, filed 2025-03-07 |
| 2022-12-31 | $1,053,042 | 10-K, filed 2024-03-13 |
| 2021-12-31 | $1,386,849 | 10-K, filed 2023-03-13 |
| 2020-12-31 | $1,851,526 | 10-K, filed 2022-03-11 |
| 2019-12-31 | $3,494,921 | 10-K, filed 2022-03-11 |
| 2018-12-31 | $2,879,426 | 10-K, filed 2021-03-12 |
| 2017-12-31 | $3,724,375 | 10-K, filed 2020-03-20 |
| 2016-12-31 | $2,520,715 | 10-K, filed 2019-03-12 |
| 2015-12-31 | $5,338,967 | 10-K, filed 2018-03-09 |
| 2014-12-31 | $4,315,444 | 10-K, filed 2017-03-13 |
| 2013-12-31 | $4,800,908 | 10-K, filed 2016-03-14 |
| 2012-12-31 | $8,086,594 | 10-K, filed 2015-03-09 |
| 2011-12-31 | $4,247,440 | 10-K, filed 2014-03-11 |
| 2010-12-31 | $4,846,791 | 10-K, filed 2013-03-12 |
| 2009-12-31 | $27,295,808 | 10-K, filed 2012-03-07 |